Australia's largest stock trading and investment forum Australia's #1 stock forum

1AI

Click for more information

0.00%

0.7¢ algorae pharmaceuticals limited

Even assuming a good result, the company will still need to...

First 20 Last

Share
Profile

Follow
whytee

17,094 Posts.

2416

06/07/17

15:30

Post #: 25707402
Share

Originally posted by mjp44 ↑

LCT will have no access to any data related to the phase 2b trial. Dr Snow and his team, as independent researchers, will have some idea how the patients are progressing based on unblinded raw data, although this certainly won't be shared with the market.

We certainly won't receive any indication specifically how the current trial is looking from an efficacy point of view. But what we do know is there are no safety concerns as the company is obligated to inform the market if an adverse events arise at any stage.

If you read back over some great comments made on this forum there is plenty that the company can do ( and hopefully are doing) between now and November in terms of setting up patient registers for the phase 3 trial, finalising a business model etc. so they are not at a standing start assuming positive phase 2b results.

Hopefully the company is able to share some of the commercial progress they have made behind the scenes assuming a positive trial outcome in their next market update.

Expand

Even assuming a good result, the company will still need to apply for permission to start commercial operations, so there could be an administrative delay.

LCT Price at posting: 10.8¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

WML

Woomera kicks off 2-pronged drilling at Mongolia's Bronze Fox Cu-Au play

LML

Lincoln Minerals to kick off fieldwork at Yallunda uranium project in the nuclear state, SA

TNC

True North shares jump on positive activity report as Cloncurry aims for Q1 production deadline

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

QGL

Quantum Graphite snags new exploration licence in SA ahead of maiden drilling

There are more pages in this discussion • 1 more message in this thread...

First 20 Last

Add 1AI (ASX) to my watchlist

(20min delay)
Last 0.7¢		Change 0.000(0.00%)		Mkt cap ! $11.81M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
22	6044404	0.6¢

Sellers (Offers)

Price($)	Vol.	No.
0.7¢	1428165	3

View Market Depth

No.	Vol.	Price($)
22	6044404	0.006
11	4577719	0.005
6	3695009	0.004
2	3100000	0.003
2	1050000	0.002

Price($)	Vol.	No.
0.007	1428165	3
0.008	2252112	10
0.009	2028673	10
0.010	2788587	5
0.011	208125	2

Last trade - 16.12pm 14/10/2024 (20 minute delay)

1AI (ASX) Chart

Day chart unavailable

SPONSORED BY